Trial Profile
Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP Within a Protocol of Controlled Ovarian Hyperstimulation in IVF in Normoresponders Women Undergoing Downregulation With GnRH Antagonist
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Menotropin (Primary) ; Recombinant follicle-stimulating hormone (Primary)
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 11 Apr 2011 New trial record